NCT04418206View on ClinicalTrials.gov

Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19

NACompletedINTERVENTIONAL
Enrollment

950

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

February 10, 2022

Study Completion Date

July 19, 2022

Conditions
Covid 19
Interventions
OTHER

patients COVID 19

Exposure to SARS-Cov2 but no symptoms (patient's family, medical staff) and General population (volunteers not exposed to SARS-Cov2)

Trial Locations (4)

06606

CH Antibes, Antibes

06414

Ch Cannes, Pneumologie, Cannes

06355

Ch Grasse, Grasse

06001

CHU de nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04418206 - Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19 | Biotech Hunter | Biotech Hunter